GlobeStar Therapeutics Corp
OTC:GSTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GlobeStar Therapeutics Corp
OTC:GSTC
|
US |
|
O
|
Old National Bancorp
F:ON1
|
US |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
|
Molinos Rio de la Plata SA
OTC:MOPLF
|
AR |
|
Meko AB
F:1OM
|
SE |
|
P
|
Poly Property Group Co Ltd
F:CMJ
|
HK |
|
Mizuno Corp
F:MIZ
|
JP |
|
F
|
Forcs Co Ltd
KOSDAQ:189690
|
KR |
|
Davictus PLC
LSE:DVT
|
MY |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
WisdomTree Inc
F:1WT
|
US |
|
La Francaise de l Energie SA
F:LFX
|
FR |
|
Shufersal Ltd
OTC:SHUFF
|
IL |
|
Promotora de Informaciones SA
MAD:PRS
|
ES |
|
T
|
Tocvan Ventures Corp
CNSX:TOC
|
CA |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for GlobeStar Therapeutics Corp.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What GlobeStar Therapeutics Does
GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is headquartered in Richland, Washington. The company went IPO on 2011-05-21. The firm is focused on introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The firm owns the global license from the inventors, who are based in Italy.
- Headquarters
- United States of America US
- IPO date
- May 21, 2011
